CCR:EGFR突变早期肺癌患者的靶向治疗,居然还有这么多讲究!( 三 )


[5]JungHA,LimJ,ChoiYL,etal.Clinical,pathological,andmolecularprognosticfactorsinpatientswithearly-stageEGFRmutantNSCLC[publishedonlineaheadofprint,2022Jul15].ClinCancerRes.2022;CCR-22-0879.doi:10.1158/1078-0432.CCR-22-0879
[6]YatabeY,KosakaT,TakahashiT,MitsudomiT.EGFRmutationisspecificforterminalrespiratoryunittypeadenocarcinoma.AmJSurgPathol.2005;29(5):633-639.doi:10.1097/01.pas.0000157935.28066.35
[8]KimMH,ChoJS,KimY,LeeCH,LeeMK,ShinDH.DiscriminatingbetweenTerminal-andNon-TerminalRespiratoryUnit-TypeLungAdenocarcinomaBasedonMicroRNAProfiles.PLoSOne.2016;11(8):e0160996.Published2016Aug30.doi:10.1371/journal.pone.0160996
责任编辑丨谭硕